Lv2
154 积分 2025-07-24 加入
Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species
1天前
已完结
Differential cytolocation and functional assays of the two major human SLC30A8 (ZnT8) isoforms
5天前
已完结
Blockade of OX40/OX40L signaling using anti‐OX40L alleviates murine lupus nephritis
6天前
已完结
Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species
15天前
已完结
Molecular dynamics simulations along with the synthesis of innovative engineered nanobodies targeting Interleukin-2
15天前
已完结
Molecular dynamics simulations along with the synthesis of innovative engineered nanobodies targeting Interleukin-2
27天前
已完结
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
28天前
已完结
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
PT101: A Treg selective agonist IL-2 mutein therapy for autoimmunity
1个月前
已完结
皖公网安备34019202002308
